Science
Hospitals expand enrollment for rare-disease programs as delivery methods improve.
Boston / London — Ebenezer Science Desk
Researchers report better targeting accuracy and fewer off-target signals in early cohorts. Access and cost remain central ethical debates.
Regulators asked for longer follow-up windows. Patient advocacy groups pushed for transparent waitlist criteria.
Biotech indexes moved as investors differentiated platform companies from single-indication bets.
Regulators asked for longer follow-up windows. Patient advocacy groups pushed for transparent waitlist criteria.
Source: Ebenezer Science Desk. Published 8 Aug 2026, 09:00 am.
Most relevant
The weather in space has the potential to impact our lives here on Earth in a fundamental way.
Read on BBC News →
